Intelligence Platform
Patents
Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9598454
Mannose derivatives for treating bacterial infections
granted patentUS 9592232
DNA-PK inhibitors
granted patentUS 9550761
Modulators of ATP-binding cassette transporters
granted patentUS 9522145
Modulators of ATP-binding cassette transporters
granted patentUS 9518056
Inhibitors of influenza viruses replication
granted patentUS 9511067
Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
granted patentUS 9504683
Heteroaryl derivatives as CFTR modulators
granted patentUS 9499497
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
granted patentUS 9487555
Prodrug of an ice inhibitor
granted patentUS 9464102
Prodrugs of pyridone amides useful as modulators of sodium channels
granted patentUS 9434717
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-me
granted patentUS 9422271
Pyrimidine compounds as tuberculosis inhibitors
granted patentUS 9421196
Amides as modulators of sodium channels
granted patentUS 9403839
Pyran-spirocyclic piperidine amides as modulators of ion channels
granted patentUS 9399648
Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
granted patentUS 9394302
Inhibitors of influenza viruses replication
granted patentUS 9393235
Pyridone amides as modulators of sodium channels
granted patentUS 9376448
DNA-PK inhibitors
granted patentUS 9371287
Process for making modulators of cystic fibrosis transmembrane conductance regulator
granted patentUS 9365557
Substituted pyrazin-2-amines as inhibitors of ATR kinase
granted patentUS 9365588
Benzoxazines as modulators of ion channels
granted patentUS 9359380
DNA-PK inhibitors
granted patentUS 9351962
Modulators of cystic fibrosis transmembrane conductance regulator
granted patentUS 9345708
Inhibitors of influenza viruses replication
granted